ADENTRA (TSE:ADEN - Get Free Report) had its price objective reduced by equities research analysts at Stifel Nicolaus from C$51.00 to C$45.00 in a research report issued on Tuesday,BayStreet.CA reports. The firm presently has a "buy" rating on the stock.
Other equities analysts also recently issued research reports about the company. Scotiabank set a C$31.00 price objective on ADENTRA and gave the company a "sector perform" rating in a research report on Thursday, June 19th. Desjardins upped their price objective on ADENTRA from C$41.00 to C$47.00 and gave the company a "buy" rating in a research report on Monday, September 29th. Finally, National Bankshares upped their price objective on ADENTRA from C$41.00 to C$42.50 and gave the company an "outperform" rating in a research report on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy".
Check Out Our Latest Research Report on ADEN
ADENTRA Price Performance
Shares of TSE ADEN traded down $2.25 during mid-day trading on Tuesday, hitting $32.80. 48,479 shares of the company's stock traded hands, compared to its average volume of 64,754. The company's 50-day moving average is $33.97 and its two-hundred day moving average is $29.82. The company has a market capitalization of $800.62 million, a P/E ratio of 18.64 and a beta of 1.25. ADENTRA has a 1 year low of $24.60 and a 1 year high of $44.03.
About ADENTRA
(
Get Free Report)
Adentra Inc is a distributor of architectural products to fabricators, home centers and professional dealers servicing the new residential, repair and remodel, and commercial construction end markets. The company operates a network in North America of 86 facilities in the United States and Canada.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ADENTRA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ADENTRA wasn't on the list.
While ADENTRA currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.